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To the Editor. We thank Dr. Guan for his interest in our
recent article [1]. He has raised some comments regard-
ing possible potential of MT and zinc as therapeutic
tools for inﬂammatory diseases. As he mentions, simply
inducing and/or enhancing metallothionein (MT) is harm-
ful, particularly in physiological condition. We want to
emphasize that for severe (lethal) inﬂammatory conditions
such as systemic inﬂammatory response syndrome (SIRS)
including acute lung injury and fulminant hepatitis in
humans, in which proper therapeutic strategy has not been
established yet, our ﬁndings using MT knockout mice
may open doors to the alternative therapeutic target. Of
course, there seems to be a large volume of problems
and issues to be overwhelmed/addressed as Guan points
out; thus, considering this, we had concluded with ton-
ing down that “...implicating MT-induction/enhancement
and/or zinc supplementation to induce/enhance MT as
possible therapeutic options for inﬂammatory diseases,
althoughadditionalresearchisneededtoconcludeitsclinical
utility.”
As for zinc supplementation, it should be taken granted
that too much zinc is harmful to health in physiological
state, as Guan insists. Experimentally, however, zinc sup-
plementation shows therapeutic and preventional eﬀects
against several pathologies such as diabetic nephropathy
[2] parasite infection [3], H. pylori-related gastritis [4], as
well as sepsis [5]. In addition, it was reported that zinc
deﬁciency increases organ damage and mortality of sepsis
in vivo [6], suggesting that zinc supplementation can protect
from the pathophysiology in the disease. Therefore, it is
attractive to speculate that zinc supplementation could be
alternative therapeutic option against refractory diseases
including severe inﬂammatory ones such as SIRS, if one
carefully monitors zinc concentration.
TheroleofMTincarcinogenesisremainscontroversialas
Guandescribes.MT(−/−) mice are reportedly susceptible to
metal- and chemical-induced carcinogenesis [7, 8]. Carcino-
genesis involves much mechanistic pathways dependent on
stimuliand/oraﬀectedcells/organs;thus,weunderstandthat
additional in vivo tests and careful clinical trials are required
to employ the molecule (MT) to therapeutic options in view
of tumorgenesis. Unfortunately, in addition, we had failed to
obtain recombinant mouse MT in our previous studies, to
validate pharmaceutical rescue for MT (−/−) mice. We want
to conduct the experiments in the future.
Finally,wehopewewillcontinuebasicresearchregarding
MT in pathophysiological conditions paying attention to the
points Dr. Guan states in his comments.
Ken-ichiro Inoue
Hirohisa Takano
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